The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Ki-67 detects a nuclear matrix-associated proliferation-related antigen : I. Intracellular localization during interphase
Abstract
Ki-67 is a commercially available mouse monoclonal antibody, which reacts with a nuclear antigen in proliferating cells. The antibody can be used to determine the growth fraction of human tumours in situ and has been shown to be of prognostic importance. In this study it is shown that in interphase cells Ki-67 reacts with an antigen, mainly present in the nucleoli. Confocal scanning laser microscopy and immunoelectron microscopy on human MR65 monolayer cells revealed that this nucleolar antigen is predominantly localized in the nucleolar cortex and in the dense fibrillar components. The Ki-67 antigen appeared to be preserved in nuclear matrix preparations obtained after in situ fractionation of MR65 cells. Despite many efforts, we could not identify the antigen in immunoblotting or immunoprecipitation assays. Testing of cell cultures of different species by means of indirect immunofluorescence revealed that the antibody reacted with human cells and with the Rhesus monkey kidney-derived cell line LLC-MK2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Cited by
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
Ki67 in breast cancer: prognostic and predictive potential
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70262-1 · Cited by 1,207
Ki-67: more than a proliferation marker
Sun, X., & Kaufman, P. D. (2018) · Chromosoma · doi:10.1007/s00412-018-0659-8 · Cited by 963
Schlüter, C., Duchrow, M., Wohlenberg, C., Becker, M. H., Key, G., Flad, H. D., & Gerdes, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.3.513 · Cited by 765
Waseem, N. H., & Lane, D. P. (1990) · Journal of Cell Science · doi:10.1242/jcs.96.1.121 · Cited by 722
Monoclonal antibody Ki‐67: its use in histopathology
BROWN, D. C., & GATTER, K. C. (1990) · Histopathology · doi:10.1111/j.1365-2559.1990.tb00788.x · Cited by 639
Shimi, T., Pfleghaar, K., Kojima, S.-I., Pack, C.-G., Solovei, I., Goldman, A. E., Adam, S. A., Shumaker, D. K., Kinjo, M., Cremer, T., et al. (2008) · Genes & Development · doi:10.1101/gad.1735208 · Cited by 519
Ki67 protein: the immaculate deception?
Brown, D. C., & Gatter, K. C. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01343.x · Cited by 509
Ki-67 protein as a tumour proliferation marker
Menon, S. S., Guruvayoorappan, C., Sakthivel, K. M., & Rasmi, R. R. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.01.011 · Cited by 479
Review: assessment of cell proliferation in histological material.
Hall, P. A., & Levison, D. A. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.3.184 · Cited by 437
Ki‐67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells
Bullwinkel, J., Baron‐Lühr, B., Lüdemann, A., Wohlenberg, C., Gerdes, J., & Scholzen, T. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20494 · Cited by 425
The Ki-67 Protein: Fascinating Forms and an Unknown Function
Endl, E., & Gerdes, J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4888 · Cited by 379
Bruno, S., & Darzynkiewicz, Z. (1992) · Cell Proliferation · doi:10.1111/j.1365-2184.1992.tb01435.x · Cited by 375
The cell proliferation antigen Ki-67 organises heterochromatin
Sobecki, M., Mrouj, K., Camasses, A., Parisis, N., Nicolas, E., Llères, D., Gerbe, F., Prieto, S., Krasinska, L., David, A., et al. (2016) · eLife · doi:10.7554/elife.13722 · Cited by 362
Quinn, C. M., & Wright, N. A. (1990) · The Journal of Pathology · doi:10.1002/path.1711600202 · Cited by 329
Yu, C. C. W., Woods, A. L., & Levison, D. A. (1992) · The Histochemical Journal · doi:10.1007/bf01047461 · Cited by 305
Cell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J. S., & Darzynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 295
Re-modelling of nuclear architecture in quiescent and senescent human fibroblasts
Bridger, J. M., Boyle, S., Kill, I. R., & Bickmore, W. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00312-2 · Cited by 274
Verheijen, R., Kuijpers, H. J. H., Driel, R. V., Beck, J. L. M., Dierendonck, J. H. V., Brakenhoff, G. J., & Ramaekers, F. C. S. (1989) · Journal of Cell Science · doi:10.1242/jcs.92.4.531 · Cited by 261
Self-citationKi67 targeted strategies for cancer therapy
Yang, C., Zhang, J., Ding, M., Xu, K., Li, L., Mao, L., & Zheng, J. (2018) · Clinical and Translational Oncology · doi:10.1007/s12094-017-1774-3 · Cited by 254
Sun, X., Bizhanova, A., Matheson, T. D., Yu, J., Zhu, L. J., & Kaufman, P. D. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00569-16 · Cited by 76
Huniadi, C. A., Pop, O. L., Antal, T. A., & Stamatian, F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.03.022 · Cited by 35
Biphasic cell cycle defect causes impaired neurogenesis in down syndrome
Sharma, V., Nehra, S., Do, L. H., Ghosh, A., Deshpande, A. J., & Singhal, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1007519 · Cited by 14
Metadata
- Authors
- Verheijen, R., Kuijpers, H. J. H., Schlingemann, R. O., Boehmer, A. L. M., Driel, R. V., Brakenhoff, G. J., & Ramaekers, F. C. S.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1989-01-01
- Volume
- 92
- Issue
- 1
- Pages
- 123-130
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W1875174047
- Cited by
- 222
- References
- 1
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.